Erasca, Inc. (ERAS)
3.725
+0.18
(+5.23%)
USD |
NASDAQ |
Dec 31, 16:00
3.725
0.00 (0.00%)
After-Hours: 18:50
Erasca Price: 3.725 for Dec. 31, 2025
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| GT Biopharma, Inc. | 0.7925 |
| ALX Oncology Holdings, Inc. | 1.135 |
| Prelude Therapeutics, Inc. | 2.885 |
| Foghorn Therapeutics, Inc. | 5.36 |
| Atea Pharmaceuticals, Inc. | 3.58 |
Price Related Metrics
| Price to Book Value | 3.038 |
| Earnings Yield | -12.10% |
| Market Cap | 1.057B |